Alps FY26 net loss narrows to USD 2.09 million; revenue rises 44% to USD 4.86 million
Reuters2026/08/06 21:57- Alps Group posted a net loss of USD 2.09 million, narrowing from USD 2.62 million a year earlier.
- Revenue rose 44% to USD 4.86 million, led by 51% growth in cellular therapy sales and a 20% increase in medical testing and aesthetics services.
- Gross margin fell 6.5 percentage points to 32.1%, reflecting a shift toward aesthetic services with profit-sharing recorded in cost of sales.
- Other operating income climbed to USD 1.33 million, driven by a USD 583,084 loan-modification gain and a USD 477,972 warrant-liability fair value gain.
- Administrative expenses increased to USD 3.5 million, including USD 1.16 million of non-recurring De-SPAC professional fees tied to the Nasdaq listing.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
The 10-year U.S. Treasury yield climbs to 4.8%, erasing the dividend advantage of utility stocks; the sector’s rebound depends on interest rate stabilization rather than technical signals.
As U.S. Treasury yields continue to climb, the American utilities sector is experiencing a significant pullback—a rise in yields not only erodes the relative appeal of the sector’s dividends but also raises financing costs for the most capital-intensive industries within this market.
Euro holds gains above 1.1600 despite robust US jobs data, traders eye ECB rate decision
Port of Tauranga wins fast-track approval for Stella Passage development
Crypto prices
More
